Oyster Point Pharmaceutica, now a part of Viatris, is a biopharmaceutical company based in West Windsor Twp, NJ. They are dedicated to the discovery, development, and commercialization of innovative therapies for ophthalmic diseases, with a focus on delivering breakthrough science to meet the needs of patients and eye care professionals.
With a strong emphasis on research and discovery, Oyster Point is committed to advancing potential therapies that can positively impact the lives of individuals living with ophthalmic diseases. They leverage their internal expertise and strategic partnerships to pioneer the development of unique ophthalmic treatments, making them a leading player in the field.
Generated from the website